The closing price of Twist Bioscience Corp (NASDAQ: TWST) was $29.24 for the day, down -4.69% from the previous closing price of $30.68. On the day, 864192 shares were traded.
Ratios:
Our analysis of TWST’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.51 and its Current Ratio is at 5.98. In the meantime, Its Debt-to-Equity ratio is 0.16 whereas as Long-Term Debt/Eq ratio is at 0.13.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Goldman on January 17, 2024, Upgraded its rating to Buy and sets its target price to $45 from $25 previously.
On September 27, 2023, Berenberg started tracking the stock assigning a Buy rating and target price of $27.
On January 05, 2023, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $33.Scotiabank initiated its Sector Outperform rating on January 05, 2023, with a $33 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 09 ’24 when Laponis Adam sold 556 shares for $33.16 per share. The transaction valued at 18,434 led to the insider holds 74,444 shares of the business.
Leproust Emily M. sold 1,132 shares of TWST for $37,057 on Apr 02 ’24. The Chief Executive Officer now owns 514,149 shares after completing the transaction at $32.74 per share. On Apr 02 ’24, another insider, Finn Patrick John, who serves as the President and COO of the company, sold 492 shares for $32.74 each. As a result, the insider received 16,106 and left with 178,380 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 6.44 while its Price-to-Book (P/B) ratio in mrq is 2.86.
Stock Price History:
Over the past 52 weeks, TWST has reached a high of $43.21, while it has fallen to a 52-week low of $11.46.
Shares Statistics:
A total of 57.56M shares are outstanding, with a floating share count of 55.30M. Insiders hold about 4.36% of the company’s shares, while institutions hold 108.70% stake in the company.
Earnings Estimates
The firm’s stock currently is rated by Toast, Inc. analysts. The consensus estimate for the next quarter is $3.34, with high estimates of $378.81 and low estimates of $29.24.
Analysts are recommending an EPS of between $Healthcare and $Healthcare for the fiscal current year, implying an average EPS of $Healthcare.
